Novo Nordisk, a leader in obesity treatments, is preparing a hit to the market with a new drug that promises to surpass even the success of Ozempic and Wegovy.
A revolutionary new drug can help overweight people. Photo: The Truth Archive
According to Bloomberg, CagriSema, the revolutionary new drug, promises unprecedented weight loss, helping patients lose more than 25% of their body weight.
The Danish company Novo Nordisk wants to be the best in treating obesity. The new drug, CagriSema, which could help those who want to lose more weight than competing drugs. Also, an American company, Eli Lilly, already has a similar drug, Zepbound, which helps patients lose about 21%. The oldest medicine of the Danes, Wegovy, helps people lose weight by 15%.
CagriSema is a special medicine that combines two substances. One of them is already known and works well. The other is new and could prevent people from regaining the pounds they’ve lost, as is often the case with other treatments.
“It’s almost as if amylin combined with anything could have a potential of one plus one equals three,” says Emily Field, an analyst at Barclays. The new drug is very promising, but manufacturing it is a complicated process. This is because the two substances must be kept separate until the last moment. For this reason, it may take longer for the medicine to be available in pharmacies.
If final studies confirm the effectiveness of the drug CagriSema, as expected in December, it could be available on the market as early as 2026. Its launch coincides with explosive growth in the slimming drug industry, which is expected to reach a value of 130 billion dollars by the year 2030.
